Who is sponsoring NCT03526913?

NCT03526913 is sponsored by Noha Mohsen Omar.

What drugs are being tested in NCT03526913?

Interventions in NCT03526913: PRP, STSG.

Is NCT03526913 still recruiting?

NCT03526913 is currently completed. Last updated 18 May 2018.

Last reviewed 2018-05-18 · How we verify

NCT03526913

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of Platelet Rich Plasma in Enhancing Graft Take in Chronic Venous Ulcers

Completed NA Last updated 18 May 2018

What this trial tests

NA trial testing PRP in Chronic Venous Hypertension With Ulcer and Inflammation in 20 participants. Completed in 1 February 2018.

Timeline

1 February 2016

Primary endpoint
1 September 2017

1 February 2018

Quick facts

Lead sponsor	Noha Mohsen Omar
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	1 February 2016
Primary completion	1 September 2017
Estimated completion	1 February 2018

Drugs / interventions tested

PRP — full drug profile →
STSG — full drug profile →

Conditions studied

Chronic Venous Hypertension With Ulcer and Inflammation — all drugs for Chronic Venous Hypertension With Ulcer and Inflammation →
Chronic Ulcer of Leg or Foot — all drugs for Chronic Ulcer of Leg or Foot →

Sponsor

Noha Mohsen Omar

Who can join

12 and older, male only, with Chronic Venous Hypertension With Ulcer and Inflammation or Chronic Ulcer of Leg or Foot. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic venous ulcers are considered a problem with a big morbidity impact on both the health facilities and patients, skin-grafting have shown not so perfect outcomes with such ulcers. In this study, the investigators compare combining autologous platelet rich plasma treatments with partial skin grafting in chronic ulcers, the results were compared to using only partial skin grafting, and among various types of chronic resistant ulcers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of PRP

Trials testing the same drug.

NCT07453953 — A Comparison of Clinical Efficacy of Mytocel MSK With AMT and PRP Injections in Patients With Knee Osteoarthritis · EARLY_PHASE1 · not yet recruiting
NCT07565844 — Intradermal Exosomes, Platelet-Rich Plasma, and Steroids for Post-Herpetic Neuralgia · NA · recruiting
NCT06384859 — Effectiveness of Extracorporeal Shockwave Therapy Combined With Platelet-rich Plasma in the Treatment of Chronic Inserti · Phase 4 · not yet recruiting
NCT06339645 — Intravesical Platelet-rich Plasma Injection in Patients With Interstitial Cystitis/Bladder-A Retrospective Study · unknown
NCT06332352 — Intra-articular Platelet-Rich Plasma for Acetabular Labral Tears · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03526913 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Noha Mohsen Omar
Last refreshed: 18 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03526913.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing